NAION is a condition where blood flow to the optic nerve is reduced, potentially leading to vision loss and is the second leading cause of optic nerve blindness
FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers WASHINGTON Health advisers met Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective
Multiple comparisons were controlled for by Benjamini-Hochberg correction
These quick-access options are available for immediate purchase, no quiz required, to support your overall wellness: GLP-1 Daily Support: Designed to complement the effects of GLP-1 agonists or support natural metabolic pathways, this supplement can be a valuable addition to your regimen
PMC2431115 FDA compounding-pathway status the 503A bulk drug substances process, the July 2324, 2026 PCAC agenda for BPC-157, KPV, and TB-500, route-specific questions for injectable GHK-Cu, and the planned GHK-Cu review: FDA 503A bulk drug substances update
Our experienced dietitians offer personalized guidance to assist you in reaching your health goals